It is a smart strategy to diversify your portfolio by investing in high-quality companies built on proven technologies.
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) Stock Drops Despite Market Gains: Important Facts to Note
CRISPR Therapeutics AG (CRSP) ended the recent trading session at $55.16, demonstrating a -2.56% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily ...
Crispr Therapeutics maintains leadership in gene editing, with shares up 75% YTD and renewed investor interest after positive CTX-310 data. CRSP's in-vivo therapy shows promising early results, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback